NASDAQ · STOCK

Merck & Co.

MRK Pharmaceuticals Unknown Updated July 08, 2026
$125.97
52W $76.66 – $130.29
56/100
$318.31B
35.5
0.21
AI Committee Verdict
Lean Buy
-10.7%
100%
Bull & Bear Case
Bull Case
  • Positive MACD histogram signals bullish momentum.
  • Daily trend: uptrend.
  • Weekly trend: uptrend.
  • Daily and weekly trends are both bullish — multi-timeframe alignment, highest confidence.
  • Daily volatility (ATR%) above ~3% is treated as elevated risk.
Bear Case
Insufficient data for bear case.
AI Investment Committee
Committee Consensus As of July 08, 2026
Overall Committee Score
56/100
The AI Investment Committee is an ensemble of six specialized analytical agents: Value Analyst, Technical Analyst, Growth Analyst, Risk Analyst, Macro Analyst, and News Analyst. Each agent independently evaluates MRK using dedicated data signals, then the committee aggregates their verdicts into a final score and recommendation. This multi-agent approach reduces individual model bias and provides a more balanced investment assessment.
View Full Committee Breakdown in Terminal →
Technical Analysis
RSI (14)
54.6
Neutral
MACD Histogram
0.493
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Mixed
Bollinger %B
0.69
Inside Bands
Price vs Moving Averages
EMA 9
$126.21 Below
EMA 21
$123.22 Above
EMA 50
$119.87 Above
EMA 200
$110.23 Above
Fundamental Analysis
Valuation
32
Growth
16
Profitability
82
Financial Health
70
Valuation
P/E Ratio 35.5×
P/B Ratio 4.97×
PEG Ratio
Dividend Yield 2.64%
52W High $130.29
52W Low $76.66
Quality & Growth
ROE 1793.0%
ROA 697.0%
Gross Margin 7807.0%
Operating Margin 1818.0%
Revenue Growth YoY +289.0%
Debt / Equity 0.94
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of 35.5 (rich relative to a 15-40x range); Price-to-book of 5.0x; Revenue growth (YoY) of 2.9%; EPS growth (YoY) of -48.3%; Return on equity of 17.9%; Return on assets of 7.0%; Net margin of 13.6%; Gross margin of 78.1%; Current ratio of 1.54 (healthy short-term liquidity); Debt-to-equity of 0.94; Earnings-history trend unavailable; growth based on TTM year-over-year only.
Key Risks
Risk data not available for MRK.
Get the Full MRK Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal → Mobile